Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 54th Annual Meeting of the American Society of Hematology
Improving Outcomes in Disorders of Complement Activation
Atlanta, Georgia / December 8-11, 2012
Atlanta - Paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) are chronic, life-threatening hematologic conditions that have limited therapeutic options. Both conditions arise from uncontrolled complement...
PRIORITY PRESS - 2012 CTRC-AACR San Antonio Breast Cancer Symposium
Better Survival with Endocrine Therapy for Metastatic Breast Cancer
San Antonio, Texas / December 4-8, 2012
San Antonio - Metastatic progression or recurrence of advanced breast cancer (BC) remains essentially an incurable disease. In the absence of curative therapy, interventions that extend survival and/or maintain quality of life have...
PRIORITY PRESS - 10th Canadian Immunization Conference
Nasopharyngeal colonization and disease transmission: Eradication of Vaccine-Specific Organisms Dramatically Reduces Disease Incidence in Recipients/Non-Recipients Alike
Vancouver, BC / December 3-5, 2012
Vancouver - Asymptomatic nasopharyngeal (NP) colonization by typical colonizing bacteria, most notably Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae is a prerequisite for the development of local and invasive...
PRIORITY PRESS -10th Canadian Immunization Conference
Improving Influenza Protection in Seniors with Adjuvanted Vaccines
Vancouver, BC / December 3-5, 2012
Vancouver - Immunosenescence significantly increases the likelihood of the elderly acquiring serious infections including influenza. If hospitalized, they are at risk for increasing frailty and disabilities. Trivalent inactivated vaccines...
PRIORITY PRESS - 10th Canadian Immunization Conference
Invasive Meningococcal Disease: Focus on the New Serogroup B Disease Vaccine
Vancouver, BC / December 3-5, 2012
Vancouver - Each year in Canada, approximately 200 individuals are affected by invasive meningococcal disease (IMD), and about half of them are children. Mortality from IMD has remained essentially unchanged since the 1950s with a...
PRIORITY PRESS - 63rd McGill Annual Refresher Course for Family Physicians
Update on Family Medicine: Oral Anticoagulants, Stroke Management, Ovarian Cancer
Montréal, Quebec / November 26-28, 2012
Montreal - At this year’s McGill Refresher Course, delegates heard about potentially practice-altering patient management strategies for common conditions. In a plenary session, they were informed about using dabigatran, rivaroxaban...
PRIORITY PRESS - 4th European Multidisciplinary Meeting on Urological Cancers (EMUC 2012)
Targeting the Androgen Receptor in Castrate-resistant Prostate Cancer: A Step Forward
Barcelona, Spain / November 16-18, 2012
Barcelona - In prostate cancer, medical or surgical androgen ablation therapy leads to tumour regression and a rapid decline in prostate-specific antigen (PSA). However, progression of the cancer despite castrate levels of testosterone is a...
PRIORITY PRESS - 76th Annual Meeting of the American College of Rheumatology (ACR)
Protection Against Radiologic Progression in Rheumatoid Arthritis with JAK Inhibition Appears Similar to IV Biologics
Washington, DC / November 10-14, 2012
Washington, DC - Oral agents that target intracellular pathways of inflammation are showing remarkable similarities to injectable monoclonal antibodies in the control of rheumatoid arthritis (RA). Along with phase III data supporting the...
MEDICAL FRONTIERS - 63rd Annual Meeting of the American Association for the Study of Liver Diseases
Direct-acting Antiviral Agents in Chronic HCV Therapy: Exploring Less Complex Regimens
Boston, Massachusetts / November 9-13, 2012
Boston - Therapy for chronic hepatitis C viral infections has changed significantly, thanks to the development of direct-acting antiviral agents that target specific vulnerabilities of the virus in all or most of its variant forms....